Trial Profile
Clinical Trials Insight: 700015336
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 29 Sep 2006
Price :
$35
*
At a glance
- Drugs Raseglurant (Primary)
- Indications Panic disorder
- Focus Therapeutic Use
- Sponsors Addex Therapeutics
- 29 Sep 2006 New trial record.